Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Structural Insights into Notum Covalent Inhibition

Journal article

Zhao Y. et al, (2021), Journal of Medicinal Chemistry, 64, 11354 - 11363

Notum deacylates octanoylated ghrelin

Journal article

Zhao Y. et al, (2021), Molecular Metabolism, 49, 101201 - 101201

Small-molecule inhibitors of carboxylesterase Notum

Journal article

Zhao Y. et al, (2021), Future Medicinal Chemistry, 13, 1001 - 1015

Structural basis of semaphorin‐plexin cis interaction

Journal article

Rozbesky D. et al, (2020), The EMBO Journal, 39

Cell guidance ligands, receptors and complexes - orchestrating signalling in time and space.

Journal article

Rozbesky D. and Jones EY., (2020), Current opinion in structural biology, 61, 79 - 85

Antiepileptic Drug Carbamazepine Binds to a Novel Pocket on the Wnt Receptor Frizzled-8

Journal article

Zhao Y. et al, (2020), Journal of Medicinal Chemistry, 63, 3252 - 3260

Scaffold-hopping identifies furano[2,3-d]pyrimidine amides as potent Notum inhibitors.

Journal article

Atkinson BN. et al, (2020), Bioorganic & medicinal chemistry letters, 30

iASPP mediates p53 selectivity through a modular mechanism fine-tuning DNA recognition

Journal article

Chen S. et al, (2019), Proceedings of the National Academy of Sciences, 116, 17470 - 17479

Designer protein delivers signal of choice

Journal article

Jones EY., (2019), Nature, 565, 165 - 166

Notum - an extracellular protein deacylase that suppresses Wnt signalling

Conference paper

Jones EY. et al, (2017), ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 73, C260 - C260

Load More